Welcome to the e-CCO Library!

P476: Fermentable carbohydrates (FODMAPs) as triggers of functional gastrointestinal symptoms in patients with quiescent inflammatory bowel disease: a double-blind, placebo-controlled, randomised, cross-over re-challenge trial
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Cox*1, A. Prince1, 2, C. Myers1, 3, P. M. Irving1, 4, J. O. Lindsay5, M. C. Lomer1, 4, K. Whelan1

Created: Friday, 22 February 2019, 9:49 AM
P476: Sigmoidostomy or Hartman's procedure during laparoscopic subtotal colectomy for acute colitis complicating inflammatory bowel disease? A comparative study in 129 consecutive patients
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Mege D.*1, Buskens C.2, Maggiori L.1, Stellingwerf M.2, Bemelman W.2, Panis Y.1

Created: Wednesday, 20 February 2019, 10:36 AM
P476: Using small bowel and colon video capsule endoscopy to optimise Crohn’s disease therapy may improve patient quality of life
Year: 2018
Source: ECCO '18 Vienna
Authors:

R. Saunders1*, M. Blüher1, R. Torrejon Torres1, M.J. Williams2, K. Richardson2, L. Kosinski3

Created: Thursday, 21 February 2019, 9:14 AM
P477 Italian real-life study evaluating the long-term effectiveness of vedolizumab for the treatment of inflammatory bowel disease: the elderly cohort
Year: 2020
Source:

ECCO'20 Vienna

Authors:

D. Pugliese, G. Privitera, A. Armuzzi, LIVE IG-IBD study group (Ambrogio Orlando and Federica Crispino – AZ.Osp. Ospedali Riuniti ‘Villa Sofia-Cervello’ Palermo Nicolò Mezzina and Alessandro Massari – ASST Fatebenefratelli Sacco Department of Biochemical and Clinical Sciences University of Milan Milan Lucienne Pellegrini and Fabiana Castiglione – AOU ‘Federico II’ Napoli Lucrezia Laterza and Franco Scaldaferri – CEMAD Fondazione Policlinico Universitario A. Gemelli IRCCS Roma Anna Viola and Walter Fries – Policlinico Messina Pietro Soru and Flavio Caprioli – Fondazione IRCCS Cà Granda Ospedale Policlinico Milan Maria Cappello and Barbara Scrivo – Universita’ di Palermo Policlinico Paolo Giaccone Palermo Brigida Barberio and Edoardo Savarino – University of Padua - Azienza Ospedaliera di Padova Padova Chiara Ricci – Università degli Studi di Brescia Ospedali Civili Brescia Brescia Dario Pluchino – AOU Policlinico Vittorio Emanuele Catania Maria Lia Scribano – San Camillo-Forlanini Rome Lorenzo Bertani Azienda Ospedaliera Universitaria Pisana Pisa Renato Sablich – Azienda per l’Assistenza Sanitaria n. 5 ‘Friuli Occidentale’ Pordenone Luca Pastorelli – University of Milan IRCCS Policlinico San Donato Milan Francesco Manguso – AORN A. Cardarelli Napoli Angela Variola – IRCCS Sacro Cuore Don Calabria Negrar di Valpolicella (VR) Antonio Di Sario – Università Politecnica delle Marche Ospedali Riuniti - University Hospital Ancona Laurino Grossi – G d’Annunzio University Ospedale Spirito Santo Pescara Davide Giuseppe Ribaldone – University of Turin Turin Giuseppe Biscaglia – IRCCS Ospedale Casa Sollievo della Sofferenza San Giovanni Rotondo (FG) Pierenrico Lecis – Ospedale S.Maria del Prato - ULSS 1 Dolomiti Belluno Paola Balestrieri – Unviersità Campus Biomedico Roma Gianmarco Mocci – AOU G Brotzu Cagliari Angelo Viscido – University of L’Aquila L’Aquila Maria Carla Di Paolo Azienda Ospedaliera San Giovanni Addolorata Roma Sara Onali – University of Rome Tor Vergata Rome Stefano Rodinò – Azienda Ospedaliera ‘Pugliese-Ciaccio’ Catanzaro Marina Coletta – ASST Santi Paolo e Carlo-Ospedale San Paolo Polo Universitario Milano Mariabeatrice Principi – Azienda Ospedaliera Universitaria Policlinico di Bari Bari Agnese Miranda – Università della Campania Luigi Vanvitelli II Policlinico di Napoli Napoli Arnaldo Amato – Valduce hospital Como Cristina Bezzio – Rho Hospital ASST Rhodense Rho Carlo Petruzzellis – Istituto Ospedaliero Fondazione Poliambulanza Brescia Silvia Mazzuoli – Osp San Nicola Pellegrino ASL BT Trani Stefano Festa – San Filippo Neri Hospital Rome Alessandro Sartini – Azienda Ospedaliero-Universitaria Policlinico di Modena Modena Libera Frangiulo – Ospedale SS. Annunziata di Taranto Taranto Sara Gallina – Ospedale Belcolle Viterbo Giorgia Bodini – University of Genoa Genoa)

Created: Thursday, 30 January 2020, 10:12 AM
P477: Assessment of treatment sequence and real-world outcomes in patients with Ulcerative Colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Chen, J.(1);Zhao, Y.(1);Liu, T.(1);Candela, N.(2);Lasch, K.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P477: Clinical remission by legacy vs. FDA definitions: definition justification and results from UNIFI Study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

W. J. Sandborn*1, R. Strauss2, H. Zhang2, J. Johanns2, P. Szapary2, C. Marano2, S. Danese3

Created: Friday, 22 February 2019, 9:41 AM
P477: Effect of tumour necrosis factor antagonists on avoiding surgery in stricturing Crohn’s disease: a tertiary centre real-life experience
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Allocca*1, G. Fiorino1, C. Bonifacio2, A. Spinelli3, A. Repici4, A. Malesci5, 6, L. Balzarini2, S. Danese1, 7

Created: Friday, 22 February 2019, 9:49 AM
P477: Patient satisfaction and cost saving analysis of telemedicine in patients with inflammatory bowel disease.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Bossa, F.(1)*;Carparelli, S.(1);Guerra, M.(1);Cocomazzi, F.(1);Martino, G.(1);Annese, M.(1);Nardella, M.(1);Bellucci, N.(2);Gagliardi, R.(3);Terracciano, F.(1);Pacilli, L.(4);Perri, F.(1);
Created: Friday, 14 July 2023, 11:05 AM
P477: Rectal bleeding and stool frequency improvement with tofacitinib retreatment in patients with Ulcerative Colitis after treatment interruption: Results from OCTAVE Open
Year: 2022
Source: ECCO'22
Authors: Allegretti, J.R.(1);Gecse, K.B.(2);Chiorean, M.V.(3);Argollo, M.(4);Guo, X.(5);Lawendy, N.(5);Su, C.(5);Mundayat, R.(6);Paulissen, J.(6);Salese, L.(5);Irving, P.M.(7);
Created: Friday, 11 February 2022, 3:56 PM
P477: The efficacy of adalimumab for the treatment of Korean patients with ulcerative colitis and predictors of response: Preliminary results
Year: 2018
Source: ECCO '18 Vienna
Authors:

C.H. Choi1*, S.J. Park2, J.P. Im3, H.J. Kim4, K.-M. Lee5, J.W. Kim6, S.-A. Jung7, J. Lee8, S.B. Kang9, S.J. Shin10, E.S. Kim11, Y.S. Kim12, T.O. Kim13, H.-S. Kim14, D.I. Park15, H.K. Kim16, E.S. Kim17, J.Y. Jin18, D. Teng19

Created: Thursday, 21 February 2019, 9:14 AM
P478 Thiopurines’ metabolites levels and drug toxicity: a systematic review and meta-analysis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

P.C. Sousa1, M. Estevinho2, C.C. Dias3, D. Martins1, E. Cancela1, F. Pires1, C. Carvalho1, P. Ministro1, F. Magro2

Created: Thursday, 30 January 2020, 10:12 AM
P478: Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard-dose subcutaneous maintenance therapy: an observational multicentre study
Year: 2021
Source: ECCO'21 Virtual
Authors: Olmedo-Martín, R.(1);Martín-Rodríguez, M.D.M.(2);Lorenzo-González, L.(3);Lázaro-Sáez, M.(4);Lopez-Vico, M.(2);Hernández-Martínez, Á.(5);Argüelles-Arias, F.(3);Vázquez-Morón, J.M.(6);
Created: Wednesday, 2 June 2021, 4:12 PM
P478: How often high-dose budesonide is necessary for maintenance treatment of collagenous colitis? Efficacy of azathioprine to maintain budesonide-free clinical remission
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

F. Fernández-Bañares*1, M. Piqueras2, D. Guagnozzi3, V. Robles4, A. Ruiz-Cerulla5, M. J. Casanova6, J. P. Gisbert6, D. Busquets7, A. Lucendo8, Y. Arguedas9, L. Fernández10

Created: Friday, 22 February 2019, 9:49 AM
P478: Immunogenicity is not the driving force of treatment failure in vedolizumab-treated inflammatory bowel disease patients
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

N. Van den Berghe*1, B. Verstockt2,3, S. Tops1, M. Ferrante2,3, S. Vermeire2,3, A. Gils1

Created: Friday, 22 February 2019, 9:41 AM
P478: Platelet-related indicators for predicting vedolizumab response in patients with Ulcerative Colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Jiao, J.(1)*;Liu, W.(1);Wang, B.(1);Cao, H.(1);
Created: Friday, 14 July 2023, 11:05 AM
P478: The current place of probiotics in treatment of pouchitis: systematic review
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Lichtenstein L., Avni I., Ben-Bassat O.

Created: Wednesday, 20 February 2019, 10:36 AM
P478: The role of proactive measurement of adalimumab trough levels and antibodies to adalimumab in Greek patients with Inflammatory Bowel Disease
Year: 2022
Source: ECCO'22
Authors: Orfanoudaki, E.(1);Gazouli, M.(2);Theodoraki, E.(1);Foteinogiannopoulou, K.(1);Andreou, N.P.(2);Koutroubakis, I.E.(1);
Created: Friday, 11 February 2022, 3:56 PM
P478: Treatment with ferric maltol associated with improvements in quality of life for IBD patients with iron deficiency anaemia
Year: 2018
Source: ECCO '18 Vienna
Authors:

C. Schmidt1,2*, D. Baumgart3, B. Bokemeyer4, C. Büning5, S. Howaldt6, A. Stallmach2, C. Singfield7, G. Tremblay8, T. Jones7

Created: Thursday, 21 February 2019, 9:14 AM
P479 The effect of adalimumab on linear growth in children with Crohn’s disease: a post hoc analysis of the PAILOT randomised control trial
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Matar1, R. Shamir2, D. Turner3, E. Broide4, B. Weiss5, O. Ledder6, A. Guz-Mark2, F. Rinawi2, S. Cohen7, C. Topf-Olivestone8, R. Shaoul9, B. Yerushalmi10, S. Ben-Horin11, A. Assa2

Created: Thursday, 30 January 2020, 10:12 AM
P479: Analysis of haematological changes in tofacitinib-treated patients with ulcerative colitis across Phase 3 induction and maintenance studies
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

G. R. Lichtenstein1, G. T. Moore*2,3, A. Soonasra4, C. I. Nduaka4, K. Kwok5, L. Wang6, N. Lawendy4, G. Chan4, C. Su4, E. V. Loftus Jr.7

Created: Friday, 22 February 2019, 9:41 AM